Jialong Zeng
Overview
Explore the profile of Jialong Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao Y, Lan D, Ke X, Zheng W, Zeng J, Niu N, et al.
Heliyon
. 2024 Jun;
10(11):e32287.
PMID: 38912481
Background: is commonly mutated in lung adenocarcinoma (LUAD). However, its role in the pathogenesis of LUAD remains undefined. -mutant LUAD represents a distinct subset of non-small cell lung cancer (NSCLC)....
2.
Zeng J, Ren Y, Tan C, Yuan Y, Li J, Yu Z
Micromachines (Basel)
. 2023 Aug;
14(8).
PMID: 37630104
This paper proposes a novel 8-18 GHz 90° switched T-type phase shifter (TPS). In contrast to the conventional TPS, the proposed TPS adds a compensation capacitance to greatly enhance the...
3.
Li J, Yuan Y, Yuan B, Fan J, Zeng J, Yu Z
Micromachines (Basel)
. 2023 Jun;
14(6).
PMID: 37374861
To meet the application requirements of broadband radar systems for broadband power amplifiers, a Ku-band broadband power amplifier (PA) microwave monolithic integrated circuit (MMIC) based on a 0.15 µm gallium...
4.
Zheng W, Niu N, Zeng J, Ke X, Jin S
Transl Cancer Res
. 2022 Nov;
11(10):3895-3902.
PMID: 36388025
Background: Epidermal growth factor receptor () exon 19 deletion (19del) and the exon 21 L858R point mutation are the most established predictive factors for the efficacy of EGFR-tyrosine kinase inhibitor...
5.
Niu N, Zeng J, Ke X, Zheng W, Fu C, Lv S, et al.
Oncol Lett
. 2022 Mar;
23(4):131.
PMID: 35251351
5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), a catalysing enzyme in the purine biosynthetic pathway, has been previously reported to be upregulated and to participate in myeloma and hepatocellular carcinoma progression. In...
6.
Huang L, Zhang F, Zeng J, Guo H, Liu S, Wei X, et al.
Ann Hematol
. 2017 Nov;
97(1):149-159.
PMID: 29150811
The prognostic value of anaplastic lymphoma kinase (ALK) expression in patients with anaplastic large-cell lymphoma (ALCL) remains controversial. Data on the clinical features of ALCL in a Chinese population are...